US · Healthcare

StateHouse Holdings Inc (STHZF)

Drug Manufacturers - Specialty & Generic

StateHouse Holdings Inc (STHZF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for STHZF

P/E ratio

18.00

StateHouse Holdings Inc (STHZF) — FAQ

What is STHZF's P/E ratio?

The price-to-earnings (P/E) ratio for StateHouse Holdings Inc (STHZF) is 18.00 (data as of 2026-05-23).

Does StateHouse Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for StateHouse Holdings Inc (STHZF). Check the MyAverix Finance app for the latest dividend data.

What sector is StateHouse Holdings Inc in?

StateHouse Holdings Inc (STHZF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is STHZF listed on?

STHZF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)